Inclusion on a compounding list is an entirely different regulatory pathway
China: Region Analysis Warning letters issued to Chinese pharmaceutical manufacturers in 2025 demonstrate a pattern of "Testing into Compliance" facilitated by weak computer controls
When formatted as an oral spray, the ease of use drives patient compliance to near-perfect levels, ensuring that the prescribed clinical outcomes are actually achieved
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 246 million patient records from 1,400 hospitals and more than 32,500 clinics from all 50 states and Lebanon
Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)
FAIR Health data serve as an official reference point in support of certain state balance billing laws that protect consumers against bills for surprise out-of-network and emergency services